NovaBay Pharmaceuticals, Inc. (NBY)
NYSEAMERICAN: NBY · Real-Time Price · USD
1.860
+0.010 (0.54%)
At close: Jan 30, 2026, 4:00 PM EST
1.840
-0.020 (-1.08%)
After-hours: Jan 30, 2026, 6:47 PM EST
NovaBay Pharmaceuticals Employees
As of December 31, 2024, NovaBay Pharmaceuticals had 14 total employees, including 13 full-time and 1 part-time employees. The number of employees decreased by 12 or -46.15% compared to the previous year.
Employees
14
Change (1Y)
-12
Growth (1Y)
-46.15%
Revenue / Employee
$735,857
Profits / Employee
$231,643
Market Cap
234.68M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2024 | 14 | -12 | -46.15% | 13 | 1 |
| Dec 31, 2023 | 26 | -7 | -21.21% | 24 | 2 |
| Dec 31, 2022 | 33 | 2 | 6.45% | 29 | 4 |
| Dec 31, 2021 | 31 | 6 | 24.00% | 29 | 2 |
| Dec 31, 2020 | 25 | -3 | -10.71% | 22 | 3 |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Nautilus Biotechnology | 124 |
| Adlai Nortye | 123 |
| Heron Therapeutics | 122 |
| Silence Therapeutics | 116 |
| MediWound | 111 |
| Tonix Pharmaceuticals Holding | 81 |
| Armata Pharmaceuticals | 60 |
| Achieve Life Sciences | 25 |
NBY News
- 3 months ago - NovaBay Pharmaceuticals, Inc. Regains Compliance with NYSE American Continued Listing Standards - GlobeNewsWire
- 4 months ago - NovaBay Pharmaceuticals Issues a Reminder of Important Information Regarding the Pending Special Dividend and Upcoming 2025 Annual Meeting - GlobeNewsWire
- 5 months ago - NovaBay Pharmaceuticals Announces One-Time Special Cash Dividend of $0.80 Per Share - GlobeNewsWire
- 5 months ago - NovaBay Pharmaceuticals Enters Into $6 Million Securities Purchase Agreement with Investor David E. Lazar - GlobeNewsWire
- 11 months ago - NovaBay Pharmaceuticals to Hold Special Meeting of Stockholders - Business Wire
- 1 year ago - NovaBay Pharmaceuticals Completes the Sale of its Eyecare Business to PRN and Further Adjourns its Special Meeting of Stockholders on Dissolution Proposal - Business Wire
- 1 year ago - NovaBay Pharmaceuticals Announces the Further Adjournment of the Special Meeting of Stockholders - Business Wire
- 1 year ago - NovaBay CEO Letter to Stockholders Urges a FOR Vote at Upcoming Reconvened Special Meeting - Business Wire